
Cetirizine (5mg) + Ambroxol (30mg) + Phenylephrine (5mg) + Paracetamol (325mg)
Active composition
+3 more active ingredients
Cetirizine acts as a competitive antagonist of histamine H1 receptors, thereby reducing the effects of histamine and alleviating allergic symptoms.
Ambroxol stimulates the secretion of mucus and reduces its viscosity, facilitating easier expectoration.
Phenylephrine activates alpha-adrenergic receptors, leading to vasoconstriction and reduced blood flow to nasal mucosa, thereby decreasing swelling and congestion.
Paracetamol works by inhibiting cyclooxygenase (COX) enzymes, leading to reduced synthesis of prostaglandins in the brain, which are responsible for pain and fever.
Medical applications
Kolki-Plus Tablet is a combination medication formulated to provide symptomatic relief from allergic rhinitis, nasal congestion, cough, and associated fever. Each tablet contains Cetirizine 5 mg, an antihistamine that selectively inhibits peripheral H1 receptors, thereby reducing allergic symptoms such as sneezing, itching, and rhinorrhea. Phenylephrine 5 mg acts as a nasal decongestant by stimulating alpha-adrenergic receptors, leading to vasoconstriction and decreased nasal mucosal edema. Ambroxol 30 mg serves as a mucolytic agent, enhancing the clearance of respiratory tract secretions by breaking down mucus, facilitating expectoration and alleviating cough. Paracetamol 325 mg provides analgesic and antipyretic effects, effectively reducing fever and relieving mild to moderate pain. The synergistic action of these components makes Kolki-Plus Tablet suitable for managing upper respiratory tract infections with allergic and inflammatory components. It is indicated for conditions such as common cold, allergic rhinitis with nasal congestion, bronchitis with productive cough, and associated fever. Caution is advised in patients with hypertension, cardiac disorders, or hepatic impairment. Use under medical supervision is recommended to ensure appropriate dosing and to monitor for potential side effects such as drowsiness, dry mouth, or gastrointestinal discomfort.
How to use Kolki-Plus Tablet Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Kolki-Plus Tablet may be taken with or without food, but it is better to take it at a fixed time.
Important precautions
Based on clinical trials and patient reports.
Overall Tolerance
Common Side Effects
It is unsafe to consume alcohol with Kolki-Plus Tablet.
High Risk
Information regarding the use of Kolki-Plus Tablet during pregnancy is not available. Please consult your doctor.
Medical Advice
It is not known whether Kolki-Plus Tablet alters the ability to drive. Do not drive if you experience any symptoms that affect your ability to concentrate and react.
Exercise Caution
There is limited information available on the use of Kolki-Plus Tablet in patients with liver disease. Please consult your doctor.
Regular Checkup
Information regarding the use of Kolki-Plus Tablet during breastfeeding is not available. Please consult your doctor.
Consult Doctor
There is limited information available on the use of Kolki-Plus Tablet in patients with kidney disease. Please consult your doctor.
Regular Checkup
0 reviews for Kolki-Plus Tablet

Cetirizine (5mg) + Phenylephrine (5mg) + Ambroxol (30mg) + Paracetamol (325mg)
Cheaper alternative availability
This medicine doesn't have a cheaper alternative with the same composition. Our health advisors can help you find other savings options based on your prescription.
Active composition
+3 more active ingredients
Cetirizine acts as a competitive antagonist of histamine H1 receptors, thereby reducing the effects of histamine and alleviating allergic symptoms.
Ambroxol stimulates the secretion of mucus and reduces its viscosity, facilitating easier expectoration.
Phenylephrine activates alpha-adrenergic receptors, leading to vasoconstriction and reduced blood flow to nasal mucosa, thereby decreasing swelling and congestion.
Paracetamol works by inhibiting cyclooxygenase (COX) enzymes, leading to reduced synthesis of prostaglandins in the brain, which are responsible for pain and fever.
Medical applications
Kolki-Plus Tablet is a combination medication formulated to provide symptomatic relief from allergic rhinitis, nasal congestion, cough, and associated fever. Each tablet contains Cetirizine 5 mg, an antihistamine that selectively inhibits peripheral H1 receptors, thereby reducing allergic symptoms such as sneezing, itching, and rhinorrhea. Phenylephrine 5 mg acts as a nasal decongestant by stimulating alpha-adrenergic receptors, leading to vasoconstriction and decreased nasal mucosal edema. Ambroxol 30 mg serves as a mucolytic agent, enhancing the clearance of respiratory tract secretions by breaking down mucus, facilitating expectoration and alleviating cough. Paracetamol 325 mg provides analgesic and antipyretic effects, effectively reducing fever and relieving mild to moderate pain. The synergistic action of these components makes Kolki-Plus Tablet suitable for managing upper respiratory tract infections with allergic and inflammatory components. It is indicated for conditions such as common cold, allergic rhinitis with nasal congestion, bronchitis with productive cough, and associated fever. Caution is advised in patients with hypertension, cardiac disorders, or hepatic impairment. Use under medical supervision is recommended to ensure appropriate dosing and to monitor for potential side effects such as drowsiness, dry mouth, or gastrointestinal discomfort.
How to use Kolki-Plus Tablet Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Kolki-Plus Tablet may be taken with or without food, but it is better to take it at a fixed time.
Important precautions
Based on clinical trials and patient reports.
Overall Tolerance
Common Side Effects
It is unsafe to consume alcohol with Kolki-Plus Tablet.
High Risk
Information regarding the use of Kolki-Plus Tablet during pregnancy is not available. Please consult your doctor.
Medical Advice
It is not known whether Kolki-Plus Tablet alters the ability to drive. Do not drive if you experience any symptoms that affect your ability to concentrate and react.
Exercise Caution
There is limited information available on the use of Kolki-Plus Tablet in patients with liver disease. Please consult your doctor.
Regular Checkup
Information regarding the use of Kolki-Plus Tablet during breastfeeding is not available. Please consult your doctor.
Consult Doctor
There is limited information available on the use of Kolki-Plus Tablet in patients with kidney disease. Please consult your doctor.
Regular Checkup
0 reviews for Kolki-Plus Tablet















